AU2001273632A1 - Polymeric, fiber matrix delivery systems for bioactive compounds - Google Patents

Polymeric, fiber matrix delivery systems for bioactive compounds

Info

Publication number
AU2001273632A1
AU2001273632A1 AU2001273632A AU7363201A AU2001273632A1 AU 2001273632 A1 AU2001273632 A1 AU 2001273632A1 AU 2001273632 A AU2001273632 A AU 2001273632A AU 7363201 A AU7363201 A AU 7363201A AU 2001273632 A1 AU2001273632 A1 AU 2001273632A1
Authority
AU
Australia
Prior art keywords
polymeric
delivery systems
fiber matrix
bioactive compounds
matrix delivery
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001273632A
Other languages
English (en)
Inventor
Meriem Benjelloun
Nikhil Dhoot
Dalia El-Sherif
Baohua Han
Saravanan Kanakasabai
Frank K. Ko
Margaret A Wheatley
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Drexel University
Original Assignee
Drexel University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Drexel University filed Critical Drexel University
Publication of AU2001273632A1 publication Critical patent/AU2001273632A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/39—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin, cold insoluble globulin [CIG]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0009—Galenical forms characterised by the drug release technique; Application systems commanded by energy involving or responsive to electricity, magnetism or acoustic waves; Galenical aspects of sonophoresis, iontophoresis, electroporation or electroosmosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T442/00—Fabric [woven, knitted, or nonwoven textile or cloth, etc.]
    • Y10T442/20—Coated or impregnated woven, knit, or nonwoven fabric which is not [a] associated with another preformed layer or fiber layer or, [b] with respect to woven and knit, characterized, respectively, by a particular or differential weave or knit, wherein the coating or impregnation is neither a foamed material nor a free metal or alloy layer
    • Y10T442/2525—Coating or impregnation functions biologically [e.g., insect repellent, antiseptic, insecticide, bactericide, etc.]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Neurosurgery (AREA)
  • Dermatology (AREA)
  • Materials For Medical Uses (AREA)
  • Medicinal Preparation (AREA)
AU2001273632A 2000-06-23 2001-06-25 Polymeric, fiber matrix delivery systems for bioactive compounds Abandoned AU2001273632A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US21403400P 2000-06-23 2000-06-23
US60214034 2000-06-23
PCT/US2001/041133 WO2002000149A1 (fr) 2000-06-23 2001-06-25 Systemes d'administration a matrice de fibres polymeres pour composes bioactifs

Publications (1)

Publication Number Publication Date
AU2001273632A1 true AU2001273632A1 (en) 2002-01-08

Family

ID=22797516

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001273632A Abandoned AU2001273632A1 (en) 2000-06-23 2001-06-25 Polymeric, fiber matrix delivery systems for bioactive compounds

Country Status (3)

Country Link
US (2) US20050158362A1 (fr)
AU (1) AU2001273632A1 (fr)
WO (1) WO2002000149A1 (fr)

Families Citing this family (70)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020081732A1 (en) 2000-10-18 2002-06-27 Bowlin Gary L. Electroprocessing in drug delivery and cell encapsulation
US6821479B1 (en) * 2001-06-12 2004-11-23 The University Of Akron Preservation of biological materials using fiber-forming techniques
US7105124B2 (en) * 2001-06-19 2006-09-12 Aaf-Mcquay, Inc. Method, apparatus and product for manufacturing nanofiber media
DE10157124A1 (de) * 2001-11-21 2003-05-28 Lohmann Therapie Syst Lts Mikrofaserhaltige Vorrichtung zur kontrollierten Freisetzung von Stoffen
US20030180268A1 (en) * 2002-02-05 2003-09-25 Anthony Atala Tissue engineered construct for supplementing or replacing a damaged organ
US20040115771A1 (en) * 2002-09-27 2004-06-17 Thomas Jefferson University Recombinant collagen-like proteins
EP3354240A3 (fr) * 2003-04-23 2018-08-29 The University of Akron Matériaux réactifs séquestrés
FI20045260A (fi) * 2003-11-18 2005-05-19 Teknillinen Korkeakoulu Menetelmä kuiturakenteen valmistamiseksi
EP1816164A4 (fr) * 2003-11-25 2008-01-02 Asahi Kasei Life & Living Corp Film mat
WO2006044832A2 (fr) * 2004-10-15 2006-04-27 The Cleveland Clinic Foundation Dispositif d'ingenierie tissulaire
SG123727A1 (en) * 2004-12-15 2006-07-26 Univ Singapore Nanofiber construct and method of preparing thereof
US10328032B2 (en) 2005-03-04 2019-06-25 Biosurfaces, Inc. Nanofibrous materials as drug, protein, or genetic release vehicles
US8771582B2 (en) 2005-03-04 2014-07-08 BioScurfaces, Inc. Electrospinning process for making a textile suitable for use as a medical article
US20060200232A1 (en) * 2005-03-04 2006-09-07 Phaneuf Matthew D Nanofibrous materials as drug, protein, or genetic release vehicles
JP4975013B2 (ja) 2005-03-11 2012-07-11 ウエイク・フオレスト・ユニバーシテイ・ヘルス・サイエンシズ 組織が工作された心臓弁の製造
CA2602029C (fr) 2005-03-11 2014-07-15 Wake Forest University Health Sciences Vaisseaux sanguins realises par genie tissulaire
US7531503B2 (en) 2005-03-11 2009-05-12 Wake Forest University Health Sciences Cell scaffold matrices with incorporated therapeutic agents
US8728463B2 (en) 2005-03-11 2014-05-20 Wake Forest University Health Science Production of tissue engineered digits and limbs
US20060204445A1 (en) * 2005-03-11 2006-09-14 Anthony Atala Cell scaffold matrices with image contrast agents
US20060204539A1 (en) 2005-03-11 2006-09-14 Anthony Atala Electrospun cell matrices
US8048446B2 (en) * 2005-05-10 2011-11-01 Drexel University Electrospun blends of natural and synthetic polymer fibers as tissue engineering scaffolds
US7704347B2 (en) * 2005-05-27 2010-04-27 Prairie Packaging, Inc. Reinforced plastic foam cup, method of and apparatus for manufacturing same
WO2006133118A1 (fr) * 2005-06-07 2006-12-14 The University Of Akron Structures de nanofibres pour le support de materiaux biologiques
CN101500606B (zh) * 2005-06-24 2013-12-04 杜克大学 基于热反应生物聚合物的直接药物送递系统
WO2007035778A2 (fr) 2005-09-19 2007-03-29 Histogenics Corporation Matrice support de cellules dont la densite des pores et la porosite sont definies specifiquement de maniere uniforme verticalement et organisees de maniere non aleatoire, et procede de preparation de celle-ci
KR100751547B1 (ko) 2005-11-21 2007-08-23 재단법인서울대학교산학협력재단 조직공학용 지지체 및 그 제조방법, 및 조직공학용지지체를 제조하기 위한 전기방사장치
CN101384272B (zh) 2005-12-20 2013-05-01 杜克大学 用于递送具有增强的药理性质的活性剂的方法和组合物
CA2636957A1 (fr) * 2006-01-12 2007-07-19 Histogenics Corporation Procede de reparation et de reconstruction de ligaments ou de tendons rompus ou de traitement de lesions ligamentaires et tendineuses
US20080220042A1 (en) * 2006-01-27 2008-09-11 The Regents Of The University Of California Biomolecule-linked biomimetic scaffolds
EP1974015A4 (fr) * 2006-01-27 2012-07-04 Univ California Squelettes biomimétiques
WO2007133570A2 (fr) * 2006-05-09 2007-11-22 University Of Akron Structures ÉlectrofilÉes et procÉdÉs de formation et d'utilisation
KR20090024249A (ko) * 2006-06-09 2009-03-06 더 리전트 오브 더 유니버시티 오브 캘리포니아 생분자-링크형 생물유사 스캐폴드
DE102006061539A1 (de) * 2006-12-27 2008-07-03 Paul Hartmann Ag Medizinisches Flächengebilde
EP2125050B1 (fr) 2007-02-01 2014-07-30 Technion Research & Development Foundation Ltd. Fibres et tissus d'albumine et leurs procédés de génération et d'utilisation
US20080260794A1 (en) * 2007-02-12 2008-10-23 Lauritzen Nels J Collagen products and methods for producing collagen products
US9056151B2 (en) * 2007-02-12 2015-06-16 Warsaw Orthopedic, Inc. Methods for collagen processing and products using processed collagen
US20100018641A1 (en) * 2007-06-08 2010-01-28 Kimberly-Clark Worldwide, Inc. Methods of Applying Skin Wellness Agents to a Nonwoven Web Through Electrospinning Nanofibers
US20100070020A1 (en) 2008-06-11 2010-03-18 Nanovasc, Inc. Implantable Medical Device
WO2008154608A1 (fr) * 2007-06-11 2008-12-18 Nanovasc, Inc. Stents
US8293531B1 (en) 2007-08-31 2012-10-23 Clemson University Research Foundation Three-dimensional ex vivo system
US8795577B2 (en) 2007-11-30 2014-08-05 Cook Medical Technologies Llc Needle-to-needle electrospinning
US7799261B2 (en) * 2007-11-30 2010-09-21 Cook Incorporated Needle-to-needle electrospinning
US20090192609A1 (en) * 2008-01-29 2009-07-30 Zimmer, Inc. Implant device for use in an implant system
US20100249924A1 (en) * 2009-03-27 2010-09-30 Allergan, Inc. Bioerodible matrix for tissue involvement
PT2464370T (pt) 2009-08-14 2017-05-17 Phasebio Pharmaceuticals Inc Péptidos vasoativos intestinais modificados
US8637109B2 (en) * 2009-12-03 2014-01-28 Cook Medical Technologies Llc Manufacturing methods for covering endoluminal prostheses
US8790699B2 (en) 2010-04-23 2014-07-29 Warsaw Orthpedic, Inc. Foam-formed collagen strand
US8460691B2 (en) 2010-04-23 2013-06-11 Warsaw Orthopedic, Inc. Fenestrated wound repair scaffold
CA3077148C (fr) 2010-06-17 2022-05-17 Washington University Pieces biomedicales avec fibres alignees
WO2012149326A1 (fr) 2011-04-29 2012-11-01 Massachusetts Institute Of Technology Traitement de couche pour des produits pharmaceutiques
US9561262B2 (en) 2011-06-06 2017-02-07 Phasebio Pharmaceuticals, Inc. Use of modified vasoactive intestinal peptides in the treatment of hypertension
US9175427B2 (en) 2011-11-14 2015-11-03 Cook Medical Technologies Llc Electrospun patterned stent graft covering
PL2644191T3 (pl) * 2012-03-30 2017-08-31 Universitat Politécnica de Catalunya Membrana włókninowa jako układ dostarczania leku
WO2013165604A1 (fr) * 2012-05-02 2013-11-07 Massachusetts Institute Of Technology Électrotraitement d'ingrédients pharmaceutiques actifs
US20140017263A1 (en) 2012-06-28 2014-01-16 Clemson University Delivery Agents for Targeted Treatment of Elastin Degradation
EP2897561B1 (fr) 2012-09-21 2020-11-04 Washington University Timbres biomédicaux avec fibres disposées spatialement
US10154918B2 (en) 2012-12-28 2018-12-18 Cook Medical Technologies Llc Endoluminal prosthesis with fiber matrix
US11173227B2 (en) * 2013-05-22 2021-11-16 The Penn State Research Foundation Wound dressings and applications thereof
CN103599090A (zh) * 2013-07-30 2014-02-26 江南大学 一种多层药物缓释纳米纤维膜及其制备方法
US9795573B2 (en) 2013-09-24 2017-10-24 Clemson University Multi-step connective tissue stabilization method and stabilized tissue formed thereby
US10092679B2 (en) 2013-10-18 2018-10-09 Wake Forest University Health Sciences Laminous vascular constructs combining cell sheet engineering and electrospinning technologies
US10213960B2 (en) 2014-05-20 2019-02-26 Massachusetts Institute Of Technology Plasticity induced bonding
KR20170044647A (ko) * 2014-08-04 2017-04-25 오스피탈 산트 호안 데 데우 활성제의 즉시 방출을 위한 시스템
US10077420B2 (en) 2014-12-02 2018-09-18 Histogenics Corporation Cell and tissue culture container
KR101810080B1 (ko) * 2015-06-01 2017-12-19 주식회사 아모라이프사이언스 치과용 멤브레인
US10632228B2 (en) 2016-05-12 2020-04-28 Acera Surgical, Inc. Tissue substitute materials and methods for tissue repair
CN105908363B (zh) * 2016-05-12 2018-07-06 华南农业大学 一种静电喷射复合薄膜及其制备方法与应用
DK3533458T3 (en) * 2018-03-02 2023-06-26 Upm Kymmene Corp A medical product comprising a bioactive molecule immobilized to nanofibrillar cellulose, and a method for preparing thereof
PT3829549T (pt) * 2018-08-03 2022-12-27 Cebiotex S L Membrana não tecida com contas como sistema de distribuição de droga
CN114053249B (zh) * 2020-08-10 2023-06-02 山东百多安医疗器械股份有限公司 一种可治疗全身骨质疏松的可降解载药薄膜及其制备工艺

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB364780A (en) 1929-12-07 1932-01-14 Anton Formhals Improvements in or relating to processes and apparatus for the production of artificial filaments
US3991766A (en) 1973-05-31 1976-11-16 American Cyanamid Company Controlled release of medicaments using polymers from glycolic acid
US4818542A (en) 1983-11-14 1989-04-04 The University Of Kentucky Research Foundation Porous microspheres for drug delivery and methods for making same
US4655777A (en) * 1983-12-19 1987-04-07 Southern Research Institute Method of producing biodegradable prosthesis and products therefrom
US5804178A (en) * 1986-11-20 1998-09-08 Massachusetts Institute Of Technology Implantation of cell-matrix structure adjacent mesentery, omentum or peritoneum tissue
US5356630A (en) * 1989-02-22 1994-10-18 Massachusetts Institute Of Technology Delivery system for controlled release of bioactive factors
US5128170A (en) 1989-05-11 1992-07-07 Kanegafunchi Kagaku Kogyo Kabushiki Kaisha Method for manufacturing medical device having a highly biocompatible surface
US5324519A (en) * 1989-07-24 1994-06-28 Atrix Laboratories, Inc. Biodegradable polymer composition
US5769830A (en) 1991-06-28 1998-06-23 Cook Incorporated Soft tip guiding catheter
WO1995005083A1 (fr) 1993-08-13 1995-02-23 Smith & Nephew Richards Inc Mousses polymeres microporeuses et surfaces microtexturees
WO1999018893A1 (fr) * 1997-10-10 1999-04-22 Drexel University Matrices a nanofibres hybrides s'utilisant comme dispositifs de genie tissulaire
CA2346841A1 (fr) * 1998-10-20 2000-04-27 Eugene Bell Composants cardiovasculaires de transplantation et leurs procedes de fabrication
US6753454B1 (en) * 1999-10-08 2004-06-22 The University Of Akron Electrospun fibers and an apparatus therefor

Also Published As

Publication number Publication date
WO2002000149A1 (fr) 2002-01-03
US20030021821A1 (en) 2003-01-30
US20050158362A1 (en) 2005-07-21
US6753311B2 (en) 2004-06-22

Similar Documents

Publication Publication Date Title
AU2001273632A1 (en) Polymeric, fiber matrix delivery systems for bioactive compounds
AU2001288388A1 (en) Substance delivery system
AU2001273178A1 (en) Stent delivery system
AU2003236947A1 (en) Modified release, multiple unit drug delivery systems
ZA200107527B (en) Delivery system for dispensing volatiles.
AU2001249239A1 (en) Shared groups rostering system
AU2002244133A1 (en) Delivery systems for mycotechnologies, mycofiltration and mycoremediation
AU2001285161A1 (en) Delivery point validation system
AU2002330886A1 (en) Novel targeted delivery system for bioactive agents
AU5914999A (en) Controlled release drug delivery
AU2002301348A1 (en) Delivery system for cyclopropenes
AU2001241662A1 (en) Pressure controlled ink delivery system
AU2001283359A1 (en) Drug release (delivery system)
AU3570099A (en) Anti-microbial agent delivery system
AUPR602401A0 (en) Sustained release delivery system
ZA200001010B (en) Microdisperse drug delivery systems.
AU2001281171A1 (en) Medication dispensing system
AU2001268879A1 (en) Injection system for gene delivery
AU2003288608A1 (en) Controlled release, multiple unit drug delivery systems
AU2002231151A1 (en) Steerable delivery system
AU2001275992A1 (en) Date specific package delivery system
AU2002354927A1 (en) Vapor delivery system
AU2001288392A1 (en) Delivery system for heparin-binding growth factors
AU2001260244A1 (en) Product delivery system
AU1738601A (en) Swellable delivery system